Investing.com -- Ipsen SA shares climbed more than 6% on Wednesday after the French biopharmaceutical company lifted its 2025 outlook and posted third-quarter sales that beat forecasts, driven by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback